Towards elimination of tuberculosis in New Zealand

被引:1
|
作者
Verrall, Ayesha J. [1 ,2 ]
Hill, Philip C. [3 ]
Thorburn, Dougal [4 ,5 ,6 ]
Maze, Michael [7 ,8 ]
Perumal, Lavinia [9 ]
Grimwade, Kate [10 ]
Thornley, Craig N. [11 ]
Freeman, Josh [12 ,13 ]
Nisbet, Mitzi [9 ]
Blackmore, Timothy K. [14 ]
机构
[1] Univ Otago Wellington, Dept Pathol & Mol Med, Wellington, New Zealand
[2] Capital & Coast Dist Hlth Board, Infect Serv, Wellington, New Zealand
[3] Univ Otago, Ctr Int Hlth, Dept Prevent & Social Med, Dunedin, New Zealand
[4] Hutt Union & Community Hlth Serv, Lower Hutt, New Zealand
[5] Te Awakairangi Hlth Network, Lower Hutt, New Zealand
[6] Univ Otago Wellington, Wellington, New Zealand
[7] Canterbury Dist Hlth Board, Resp Dept, Christchurch, New Zealand
[8] Univ Otago, Dept Med, Christchurch, New Zealand
[9] Auckland Dist Hlth Board, Auckland, New Zealand
[10] Bay Plenty Dist Hlth Board, Tauranga, New Zealand
[11] Hutt Valley Dist Hlth Board, Reg Publ Hlth, Lower Hutt, New Zealand
[12] Canterbury Dist Hlth Board, Christchurch, New Zealand
[13] Univ Otago, Dept Pathol & Biomed Sci, Christchurch, New Zealand
[14] Wellington Southern Community Labs, Wellington, New Zealand
关键词
LATENT TUBERCULOSIS; TB; PATIENT; COST;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
New Zealand could be the first country in the world to eliminate tuberculosis (TB). We propose a TB elimination strategy based on the eight-point World Health Organization (WHO) action framework for low incidence countries. Priority actions recommended by the WHO include 1) ensure political commitment, funding and stewardship for planning and essential services; 2) address the most vulnerable and hard-to-reach groups; 3) address special needs of migrants and cross-border issues; 4) identify active TB and undertake screening for latent tuberculosis infection (LTBI) in recent TB contacts and selected high-risk groups, and provide appropriate treatment; 5) optimise the prevention and care of drug-resistant TB; 6) ensure continued surveillance, programme monitoring and evaluation and case-based data management; 7) invest in research and new tools; and 8) support global TB prevention, care and control. In New Zealand, central government needs to take greater responsibility for TB policy and programme governance. Urgent action is required to prevent TB in higher risk groups including Maori communities, and to enable immigration screening to detect and treat LTBI. Clinical services need to be supported to implement new guidelines for LTBI that enable better targeting of screening and shorter, safer treatment regimens. Access to WHO recommended treatment regimens needs to be guaranteed for drug-resistant TB. Better use of existing data could better define priority areas for action and assist in the evaluation of current control activities. Access to GeneXpert (R) MTB-RIF near the point of care and whole genome sequencing nationally would greatly improve clinical and public health management through early identification of drug resistance and outbreaks. New Zealand already has a world-class TB research community that could be better deployed to assist high-incidence countries through research and training.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 50 条